These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 35032495)

  • 41. Cannabidiol as a Potential Treatment for Anxiety Disorders.
    Blessing EM; Steenkamp MM; Manzanares J; Marmar CR
    Neurotherapeutics; 2015 Oct; 12(4):825-36. PubMed ID: 26341731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression.
    Laczkovics C; Kothgassner OD; Felnhofer A; Klier CM
    Neuropsychiatr; 2021 Mar; 35(1):31-34. PubMed ID: 32052321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial.
    Mongeau-Pérusse V; Rizkallah E; Morissette F; Brissette S; Bruneau J; Dubreucq S; Gazil G; Trépanier A; Jutras-Aswad D
    J Addict Med; 2022 Sep-Oct 01; 16(5):521-526. PubMed ID: 35135986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice.
    Ledesma JC; Manzanedo C; Aguilar MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110390. PubMed ID: 34157334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of cannabidiol in the treatment of epilepsy.
    Mazurkiewicz-Bełdzińska M; Zawadzka M
    Neurol Neurochir Pol; 2022; 56(1):14-20. PubMed ID: 35211946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Cannabidiol on Locomotor Activity.
    Calapai F; Cardia L; Calapai G; Di Mauro D; Trimarchi F; Ammendolia I; Mannucci C
    Life (Basel); 2022 Apr; 12(5):. PubMed ID: 35629320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
    Peng J; Fan M; An C; Ni F; Huang W; Luo J
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder.
    Staben J; Koch M; Reid K; Muckerheide J; Gilman L; McGuinness F; Kiesser S; Oswald IWH; Koby KA; Martin TJ; Kaplan JS
    Front Neurosci; 2023; 17():1185737. PubMed ID: 37397463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development.
    Samanta D
    Epilepsy Behav; 2022 Mar; 128():108577. PubMed ID: 35151190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
    Mlost J; Bryk M; Starowicz K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
    Straiker A; Dvorakova M; Zimmowitch A; Mackie K
    Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabidiol does not display drug abuse potential in mice behavior.
    Viudez-Martínez A; García-Gutiérrez MS; Medrano-Relinque J; Navarrón CM; Navarrete F; Manzanares J
    Acta Pharmacol Sin; 2019 Mar; 40(3):358-364. PubMed ID: 30022153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of cannabidiol (CBD) for the treatment of chronic pain.
    Urits I; Gress K; Charipova K; Habib K; Lee D; Lee C; Jung JW; Kassem H; Cornett E; Paladini A; Varrassi G; Kaye AD; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):463-477. PubMed ID: 33004159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
    Melas PA; Scherma M; Fratta W; Cifani C; Fadda P
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
    Rodríguez-Muñoz M; Onetti Y; Cortés-Montero E; Garzón J; Sánchez-Blázquez P
    Mol Brain; 2018 Sep; 11(1):51. PubMed ID: 30223868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.